These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7397649)

  • 1. Simultaneous Hodgkin's disease in three siblings with identical HLA-genotype.
    Torres A; Martinez F; Gómez P; Gómez C; Garcia JM; Nuñez-Roldan A
    Cancer; 1980 Aug; 46(4):838-43. PubMed ID: 7397649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic thrombocytopenic purpura and Hodgkin's disease: report of two cases and a review of the literature.
    Kirshner JJ; Zamkoff KW; Gottlieb AJ
    Am J Med Sci; 1980; 280(1):21-8. PubMed ID: 7191634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hodgkin's disease in a Swiss family].
    Fey MF; Joss RA; Pichler WJ; Laissue JA; Riedler GF; Schmid HJ; Brunner KW
    Schweiz Med Wochenschr; 1987 May; 117(20):761-6. PubMed ID: 3589632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's disease susceptibility: linkage to the HLA locus demonstrated by a new concordance method.
    Berberich FR; Berberich MS; King MC; Engleman EG; Grumet FC
    Hum Immunol; 1983 Apr; 6(4):207-17. PubMed ID: 6221004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
    Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
    Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of HLA phenotypes in Hodgkin's disease.
    Osoba D; Falk JA; Sousan P; Ciampi A; Till JE
    Cancer; 1980 Oct; 46(8):1825-32. PubMed ID: 7427885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA genotypes in familial Hodgkin's disease. Excess of HLA identical affected subs.
    Hors J; Steinberg G; Andrieu JM; Jacquillat C; Minev M; Messerschmitt J; Malinvaud G; Fumeron F; Dausset J; Bernard J
    Eur J Cancer (1965); 1980 Jun; 16(6):809-15. PubMed ID: 7408930
    [No Abstract]   [Full Text] [Related]  

  • 8. Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance.
    Chakravarti A; Halloran SL; Bale SJ; Tucker MA
    Genet Epidemiol; 1986; 3(6):407-15. PubMed ID: 3803911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC related genetic susceptibility to Hodgkin's disease.
    Kalidi I; Masset M; Gony J; Marcelli A; Jeannet M; Irlé C; Bauters F; Tchernia G; Turpin F; Gisselbrecht C
    Nouv Rev Fr Hematol (1978); 1989; 31(2):149-52. PubMed ID: 2771630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA and susceptibility to Hodgkin's disease.
    Hors J; Dausset J
    Immunol Rev; 1983; 70():167-92. PubMed ID: 6403456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin's disease in siblings: a family study.
    Perlin E; Levine PH; McCoy J; Dean J; Herberman R
    Oncology; 1976; 33(3):116-8. PubMed ID: 189264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Hodgkin's disease. A clinical and laboratory investigation.
    Robertson SJ; Lowman JT; Grufferman S; Kostyu D; van der Horst CM; Matthews TJ; Borowitz MJ; Bigner SH
    Cancer; 1987 Apr; 59(7):1314-9. PubMed ID: 3028599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
    Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
    Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombopenic purpura revealing Hodgkin's disease].
    Godeau P; Guillevin L; de Saxce H; Le Porrier M
    Sem Hop; 1975 Oct; 51(40):2401-5. PubMed ID: 175487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined segregation and linkage analysis of 59 Hodgkin's disease families indicates the role of HLA determinants.
    Shugart YY; Collins A
    Eur J Hum Genet; 2000 Jun; 8(6):460-3. PubMed ID: 10878668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
    Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
    Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hodgkin's disease in siblings.
    Warrier RP; Cushing B; Das L; Philippart A
    Clin Pediatr (Phila); 1985 Mar; 24(3):172-3. PubMed ID: 3971646
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA in familial Hodgkin's disease. Results and a new hypothesis;
    Marshall WH; Barnard JM; Buehler SK; Crumley J; Larsen B
    Int J Cancer; 1977 Apr; 19(4):450-5. PubMed ID: 844915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA in familial Hodgkin's disease.
    Conte R; Lauria F; Zucchelli P
    J Immunogenet; 1983 Jun; 10(3):251-5. PubMed ID: 6875280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial Hodgkin's disease and associated cancer. A clinical-pathologic study.
    Lynch HT; Saldivar VA; Guirgis HA; Terasaki PI; Bardawil WA; Harris RE; Lynch JF; Thomas R
    Cancer; 1976 Nov; 38(5):2033-41. PubMed ID: 991117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.